Is EVOK or RYLD a better dividend investment in 2026?

EVOK currently yields 18.18% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: EVOK offers higher current income.

What is the dividend yield difference between EVOK and RYLD?

EVOK has a forward dividend yield of 18.18% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 5.79 percentage points.

Home › Compare › EVOK vs RYLD

EVOK vs RYLD: Dividend Comparison 2026

EVOK yields 18.18% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EVOK wins by $20.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

EVOK

● Live price

18.18%

Share price

$11.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$65.3K

Annual income

$5,522.63

Full EVOK calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — EVOK vs RYLD

📍 EVOK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EVOK	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EVOK + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EVOK pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EVOK

Annual income on $10K today (after 15% tax)

$1,545.45/yr

After 10yr DRIP, annual income (after tax)

$4,694.24/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, EVOK beats the other by $2,413.70/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EVOK + RYLD for your $10,000?

EVOK: 50%RYLD: 50%

100% RYLD50/50100% EVOK

Portfolio after 10yr

$55.3K

Annual income

$4,102.81/yr

Blended yield

7.42%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EVOK right now

EVOK

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$18.00

+63.6% upside vs current

Range: $18.00 — $18.00

Altman Z

-10.8

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EVOK buys

RYLD buys

No recent congressional trades found for EVOK or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEVOKRYLD

Forward yield	18.18% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$65.3K ✓	$45.3K
Annual income after 10y	$5,522.63 ✓	$2,682.98
Total dividends collected	$35.3K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EVOK vs RYLD ($10,000, DRIP)

Year	EVOK Portfolio	EVOK Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$12,518	$1,818.18	$11,939	$1,239.34	+$579.00 → EVOK
2	$15,522	$2,127.13	$14,158	$1,382.89	+$1.4K → EVOK
3	$19,073	$2,464.94	$16,682	$1,532.59	+$2.4K → EVOK
4	$23,239	$2,830.78	$19,537	$1,687.64	+$3.7K → EVOK
5	$28,089	$3,223.43	$22,752	$1,847.20	+$5.3K → EVOK
6	$33,697	$3,641.30	$26,355	$2,010.43	+$7.3K → EVOK
7	$40,138	$4,082.45	$30,376	$2,176.45	+$9.8K → EVOK
8	$47,492	$4,544.69	$34,847	$2,344.43	+$12.6K → EVOK
9	$55,842	$5,025.61	$39,800	$2,513.54	+$16.0K → EVOK
10	$65,274	$5,522.63	$45,269	$2,682.98	+$20.0K → EVOK

EVOK vs RYLD: Complete Analysis 2026

EVOK — Stock

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Full EVOK Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this EVOK vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EVOK vs SCHD EVOK vs JEPI EVOK vs O EVOK vs KO EVOK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.